Publications
Detailed Information
Clinical Features, Risk Factors and Outcomes of Bacteremia due to Enterococci with High-Level Gentamicin Resistance: Comparison with Bacteremia due to Enterococci without High-Level Gentamicin Resistance
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Hee-Chang | - |
dc.contributor.author | Lee, Shinwon | - |
dc.contributor.author | Jeon, Jae Hyun | - |
dc.contributor.author | Song, Kyoung-Ho | - |
dc.contributor.author | Kim, Hong Bin | - |
dc.contributor.author | Kim, Eui-Chong | - |
dc.contributor.author | Choe, Kang Won | - |
dc.contributor.author | Oh, Myoung-don | - |
dc.contributor.author | Kim, Nam Joong | - |
dc.contributor.author | Park, Sang-Won | - |
dc.contributor.author | Park, Wan Beom | - |
dc.date.accessioned | 2012-05-22T08:58:04Z | - |
dc.date.available | 2012-05-22T08:58:04Z | - |
dc.date.issued | 2010-01 | - |
dc.identifier.citation | JOURNAL OF KOREAN MEDICAL SCIENCE; Vol.25 1; 3-8 | ko_KR |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76260 | - |
dc.description.abstract | High-level gentamicin resistance (HLGR) in enterococci has increased since the 1980s, but the clinical significance of the resistance and its impact on outcome have not been established. One hundred and thirty-six patients with bacteremia caused by enterococci with HLGR (HLGR group) were compared with 79 patients with bacteremia caused by enterococci without HLGR (non-HLGR group). Hematologic malignancy, neutropenia, Enterococcus faecium infection, nosocomial infection and mono-microbial bacteremia were more common in the HLGR group than the non-HLGR group, and APACHE II scores were also higher (P<0.05, in each case). Neutropenia, monomicrobial infection, stay in intensive care at culture, and use of 3rd generation cephalosporin, were independent risk factors for acquisition of HLGR enterococcal bacteremia. Fourteen-day and 30-day mortalities were higher in the HLGR group than the non-HLGR group in univariate analysis (37% vs. 15%, P=0.001; 50% vs. 22%, P<0.001). However, HLGR was not an independent risk factor for mortality due to enterococcal bacteremia in multivariate analysis. Therefore, HLGR enterococcal bacteremia is associated with more severe comorbid conditions and higher mortality than non-HLGR enterococcal bacteremia but the HLGR itself does not contribute significantly to mortality. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | ko_KR |
dc.subject | Enterococcus | ko_KR |
dc.subject | Bacteremia | ko_KR |
dc.subject | Gentamicins | ko_KR |
dc.subject | Drug Therapy | ko_KR |
dc.subject | Combination | ko_KR |
dc.subject | HLGR | ko_KR |
dc.subject | Mortality | ko_KR |
dc.title | Clinical Features, Risk Factors and Outcomes of Bacteremia due to Enterococci with High-Level Gentamicin Resistance: Comparison with Bacteremia due to Enterococci without High-Level Gentamicin Resistance | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 장희창 | - |
dc.contributor.AlternativeAuthor | 송경호 | - |
dc.contributor.AlternativeAuthor | 박완범 | - |
dc.contributor.AlternativeAuthor | 김홍빈 | - |
dc.contributor.AlternativeAuthor | 최강원 | - |
dc.contributor.AlternativeAuthor | 오명돈 | - |
dc.contributor.AlternativeAuthor | 김의종 | - |
dc.contributor.AlternativeAuthor | 김남중 | - |
dc.contributor.AlternativeAuthor | 박상원 | - |
dc.contributor.AlternativeAuthor | 전재현 | - |
dc.contributor.AlternativeAuthor | 이신원 | - |
dc.identifier.doi | 10.3346/jkms.2010.25.1.3 | - |
dc.citation.journaltitle | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.description.citedreference | *CLSI, 2008, M100S18 CLSI | - |
dc.description.citedreference | WESSELS MR, 2008, HARRISONS PRINCIPLES, P881 | - |
dc.description.citedreference | Shaked H, 2006, SCAND J INFECT DIS, V38, P995, DOI 10.1080/00365540600868321 | - |
dc.description.citedreference | MOELLERING RC, 2005, MANDELL DOUGLAS BENN, P2411 | - |
dc.description.citedreference | Elliott TSJ, 2004, J ANTIMICROB CHEMOTH, V54, P971, DOI 10.1093/jac/dkh474 | - |
dc.description.citedreference | Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946 | - |
dc.description.citedreference | Lee K, 2004, J KOREAN MED SCI, V19, P8 | - |
dc.description.citedreference | Vergis EN, 2001, ANN INTERN MED, V135, P484 | - |
dc.description.citedreference | Lee K, 2001, J KOREAN MED SCI, V16, P262 | - |
dc.description.citedreference | Caballero-Granado FJ, 1998, J CLIN MICROBIOL, V36, P520 | - |
dc.description.citedreference | Devriese LA, 1996, J CLIN MICROBIOL, V34, P2607 | - |
dc.description.citedreference | BOYCE JM, 1994, J CLIN MICROBIOL, V32, P1148 | - |
dc.description.citedreference | WATANAKUNAKORN C, 1993, CLIN INFECT DIS, V17, P74 | - |
dc.description.citedreference | HANDWERGER S, 1993, CLIN INFECT DIS, V16, P750 | - |
dc.description.citedreference | BOYLE JF, 1993, J CLIN MICROBIOL, V31, P1280 | - |
dc.description.citedreference | GRANINGER W, 1992, CLIN INFECT DIS, V15, P49 | - |
dc.description.citedreference | WELLS VD, 1992, ANN INTERN MED, V116, P285 | - |
dc.description.citedreference | NOSKIN GA, 1991, J INFECT DIS, V164, P1212 | - |
dc.description.citedreference | CHOW JW, 1991, ANN INTERN MED, V115, P585 | - |
dc.description.citedreference | HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626 | - |
dc.description.citedreference | HOGE CW, 1991, REV INFECT DIS, V13, P600 | - |
dc.description.citedreference | MAKI DG, 1988, MEDICINE, V67, P248 | - |
dc.description.citedreference | GULLBERG RM, 1989, REV INFECT DIS, V11, P74 | - |
dc.description.citedreference | FACKLAM RR, 1989, J CLIN MICROBIOL, V27, P731 | - |
dc.description.citedreference | MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.